Erratum: lncRNA HAR1B has potential to be a predictive marker for pazopanib therapy in patients with sarcoma (Oncology Letters (2021) 21 (455) DOI: 10.3892/ol.2021.12716)

HIDEHARU YAMADA, MASANOBU TAKAHASHI, MUNENORI WATANUKI, MIKA WATANABE, SAKURA HIRAIDE, KEN SAIJO, KEIGO KOMINE, CHIKASHI ISHIOKA

Research output: Contribution to journalComment/debatepeer-review

Fingerprint

Dive into the research topics of 'Erratum: lncRNA HAR1B has potential to be a predictive marker for pazopanib therapy in patients with sarcoma (Oncology Letters (2021) 21 (455) DOI: 10.3892/ol.2021.12716)'. Together they form a unique fingerprint.

Medicine & Life Sciences